SAB Biotherapeutics Inc. (SABS)
NASDAQ: SABS
· Real-Time Price · USD
2.01
-0.09 (-4.29%)
At close: Sep 26, 2025, 3:59 PM
2.06
2.49%
After-hours: Sep 26, 2025, 06:01 PM EDT
SAB Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SABS stock have an median target of 11, with a low estimate of 9 and a high estimate of 12. The median target predicts an increase of 447.26% from the current stock price of 2.01.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 9 | 10.67 | 11 | 12 |
| Change | 347.76% | 430.85% | 447.26% | 497.01% |
Latest Analyst Insight Report
Chardan Capital maintained a Buy on SAB Biotherape... Unlock content with Pro Subscription
Updated Sep 19, 2025
| Rating | Jan 25 | Apr 25 | May 25 | Jul 25 | Aug 25 | Sep 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
166.67K
from 1.32M
Increased by -87.4%
Revenue Next Year
333.33K
from 166.67K
Increased by 100.0%
EPS This Year
-1.95
from -3.68
Increased by 47.0%
EPS Next Year
-1.03
from -1.95
Increased by 47.2%